Panteston (Testosterone)

Quick links to important sections

Panteston (Testosterone)

Treatment option: Hypogonadism

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Panteston (Testosterone)

Quick Facts

Property Description
Active ingredient Testosterone undecanoate
Form Oral capsule, Intramuscular injectable solution
Pharmacological class Androgen, Anabolic steroid
Common use Hormone replacement therapy (TRT)
Origin Synthetic derivative

Panteston (Testosterone): A Definition and Pharmacological Class

Panteston is a prescription pharmaceutical that is structurally classified as an androgen and, more broadly, an anabolic steroid, placing it within the group of male sex hormones. Its active ingredient is testosterone undecanoate, a synthetic derivative that functions as an ester prodrug of the natural hormone, testosterone. This specific chemical modification, which includes an undecanoic side chain, is critical for the drug's specialized delivery route within the body.

The fundamental role of Panteston is to provide essential hormone replacement activity. As an androgen, it is clinically recognized for replacing or supplementing the body’s endogenous testosterone when levels are deficient, which is the cornerstone of responsible androgen therapy.


Composition, Form, and Unique Delivery

The medication is supplied in two primary dosage forms: an oral capsule (soft gelatin capsule) and an intramuscular injectable solution. A distinctive feature is that the active substance is suspended in a vegetable oil base for both forms, a composition critical to its absorption mechanism. For the oral formulation, this lipophilic (fat-soluble) base allows the testosterone undecanoate prodrug to be absorbed primarily via the intestinal lymphatic system, a pathway that avoids extensive initial breakdown by the liver (first-pass metabolism). This delivery system ensures the drug successfully reaches the circulation to become active testosterone.

Once in the circulation, the drug is activated when endogenous enzymes (non-specific esterases) cleave the undecanoate chain, slowly releasing the bio-identical testosterone molecule.


General Purpose of Testosterone Replacement Therapy

The overarching general purpose of using Panteston is to serve as testosterone replacement therapy (TRT), correcting physiological states where a critical sex hormone deficiency exists. The therapeutic objective is to restore and maintain the essential biological functions and overall health dependent on adequate androgen levels in adult males.

What side effects are possible with Panteston (Testosterone)?

Possible side effects and safety information

The safety profile of testosterone undecanoate is formally documented by regulatory agencies, classifying potential effects across several body systems based on clinical trial data and post-marketing surveillance.

Adverse Reactions and Frequency

Adverse reactions are classified by frequency as observed in official regulatory documents, often grouped by system-organ classes (SOCs) such as Blood and Lymphatic, Vascular/Cardiac, Reproductive, and Psychiatric disorders. Common reactions (those occurring in ge 1/100 patients, or ge 2% incidence) often include polycythemia (increased hematocrit/hemoglobin), hypertension, increased Prostatic Specific Antigen (PSA), gynecomastia, acne, and weight increase.

Serious Adverse Reactions

Regulatory labeling specifies several serious adverse reactions. These include Major Adverse Cardiovascular Events (MACE), such as non-fatal myocardial infarction and stroke, and Venous Thromboembolism (VTE) (including deep vein thrombosis and pulmonary embolism). For the injectable formulation, rare but serious risks include Serious Pulmonary Oil Microembolism (POME) Reactions and anaphylaxis, which may occur during or immediately following administration.

Safety Considerations and Constraints

The prescribing information mandates specific safety constraints. Due to the risk of polycythemia, hematocrit monitoring is required. Similarly, monitoring of PSA levels and prostate examination is necessary due to the risk of stimulating occult prostate cancer or worsening existing Benign Prostatic Hyperplasia (BPH). Patients with pre-existing cardiac, renal, or hepatic disease may be at increased risk for edema (fluid retention). The label also notes that blood pressure increases may begin approximately three weeks after initiating or changing the dose of the oral form.

Overdose and Emergency Response

Overdose of Panteston (Testosterone)

There is limited information available specifically detailing acute, life-threatening overdose of testosterone undecanoate (Panteston). However, administering a dose significantly higher than prescribed can lead to supraphysiological (very high) testosterone levels, which may increase the risk of known adverse effects associated with testosterone use. The general management of a suspected overdose is to discontinue the medication and provide supportive and symptomatic care as necessary.

When to Seek Help

Misuse or abuse of testosterone, often involving higher doses than recommended, has been associated with serious health problems, including cardiovascular events and psychiatric manifestations. You should seek immediate emergency medical attention (call emergency services) if you experience any signs of a serious adverse event, which may be intensified in an overdose scenario.

Symptom Category Signs Requiring Immediate Medical Attention
Cardiovascular/Thromboembolic Chest pain, shortness of breath, sudden weakness or numbness on one side of the body, slurred speech, sudden severe headache.
Pulmonary Tightening of the throat, difficulty breathing, cough, dizziness, or fainting immediately after an injection.
Mental Health Severe mood changes, including suicidal thoughts or aggressive behavior.

Additionally, contact your healthcare provider immediately if you experience signs of excessive testosterone levels, such as persistent, inappropriate, or prolonged erections (priapism), or significant changes in mood like severe irritability or nervousness.

Therapeutic Uses of Panteston (Testosterone)

Understanding Panteston (Testosterone)

Panteston is an oral formulation of testosterone undecanoate, a fatty acid ester of the naturally occurring androgen testosterone. It is designed to deliver testosterone into the body via the lymphatic system, bypassing the initial filtration process of the liver. This medication is primarily utilized to address physiological conditions resulting from a deficiency in endogenous testosterone.

Main Uses: Testosterone Replacement Therapy (TRT)

The primary clinical application of Panteston is testosterone replacement therapy in males who have been diagnosed with hypogonadism. This condition occurs when the body is unable to produce sufficient levels of testosterone due to issues with the testes or the pituitary-hypothalamic axis.

Primary Hypogonadism

This includes conditions where the testicular tissue itself is affected, such as:

  • Congenital anomalies (e.g., Klinefelter syndrome)
  • Loss of testicular function due to physical injury or torsion
  • Damage resulting from toxic exposure, such as chemotherapy or heavy metal poisoning

Hypogonadotropic Hypogonadism

This involves a failure of the signals from the brain that tell the body to produce testosterone. It may be caused by:

  • Deficiencies in luteinizing hormone-releasing hormone (LHRH)
  • Pituitary or hypothalamic tumors
  • Trauma or radiation affecting the brain's hormonal centers

Benefits and Physiological Effects

When testosterone levels are restored to a physiological range using Panteston, patients typically experience improvements in several androgen-dependent systems. The benefits focus on reversing the symptoms associated with testosterone deficiency.

Physical Composition and Bone Health

Testosterone plays a critical role in maintaining musculoskeletal health. Adequate levels help in:

  • Bone Density: Reducing the risk of osteoporosis and improving bone mineral density.
  • Muscle Mass: Supporting the maintenance of lean muscle tissue and physical strength.

Metabolic and Sexual Function

Restoring testosterone levels can influence metabolic processes and reproductive health:

  • Libido: Improving sexual desire and overall sexual interest.
  • Energy Levels: Addressing chronic fatigue and low energy often associated with hormonal imbalances.
  • Secondary Sex Characteristics: Maintaining male physical traits such as body hair distribution and deepening of the voice.

Mood and Cognitive Well-being

While primarily physical in its action, testosterone replacement often correlates with improvements in quality of life factors, including:

  • Stabilization of mood and reduction in irritability.
  • Improved focus and mental clarity.

Eligibility and Restrictions for Use

Testosterone replacement therapy, such as Panteston, is primarily approved for men diagnosed with hypogonadism, a condition confirmed by consistently low morning testosterone levels and associated clinical symptoms. It is used to restore testosterone to normal physiological levels in these patients.

Testosterone is contraindicated (should not be used) in patients with certain pre-existing conditions. These include:

Contraindication Relevance
Prostate or Male Breast Cancer Testosterone can stimulate the growth of these hormone-sensitive cancers.
Pregnancy or Breastfeeding Testosterone can cause serious harm to a developing fetus and is present in breast milk.
Severe Heart, Liver, or Kidney Disease These conditions may be worsened by the fluid retention and other side effects associated with testosterone use.
High Red Blood Cell Count (Hematocrit >54%) Increases the risk of thromboembolic events, such as blood clots.

Testosterone is not approved for treating age-related low testosterone in men who are otherwise healthy or for enhancing athletic performance, strength, or physical appearance. Use in patients with a history of blood clots, severe sleep apnea, or an enlarged prostate requires careful consideration and monitoring by a healthcare professional.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for testosterone undecanoate (Panteston) is defined by pharmacodynamic and metabolic effects on co-administered medications, requiring enhanced monitoring or dosage adjustments for specific drug classes.

Documented Pharmacodynamic and Exposure Interactions

Interacting Product Category Officially Documented Interaction Outcome
Oral Anticoagulants (e.g., Warfarin) May cause changes in anticoagulant activity and is reported to increase the activity of coumarin-derived agents. This requires frequent monitoring of the International Normalized Ratio (INR).
Antidiabetic Medications (e.g., Insulin) May contribute to a decrease in blood glucose levels, which may necessitate a decrease in the required dose of antidiabetic medication.
Corticosteroids Co-administration may result in an additive effect leading to increased fluid retention (edema/oedema formation).

Interaction Constraints and Considerations

There are no drug–drug combinations explicitly listed as contraindicated in the core regulatory interaction sections. However, the risk of increased fluid retention when co-administered with corticosteroids requires careful monitoring in patients with pre-existing cardiac, renal, or hepatic disease. Furthermore, the oral capsule formulation must be taken with food to achieve the necessary absorption and bioavailability.

Mechanism of Action

How Panteston (Testosterone) Works

Panteston, a form of testosterone, exerts its primary effect through precise, multi-stage receptor- and enzyme-mediated signaling to modulate core biological processes. The drug's influence is defined by its ability to engage specific nuclear receptors and downstream pathways, leading to physiological adjustments.

Androgen Receptor Binding and Nuclear Signaling

This mechanism involves the hormone diffusing into cells and binding to the Androgen Receptor (AR), an intracellular protein. The resulting complex moves to the cell nucleus, where it acts as a transcription factor. This domain is the initial step as it initiates the hormone’s mechanism by directly controlling access to the cell's genetic machinery.

Modulating Gene Expression and Protein Synthesis

Once the AR complex binds to DNA's Hormone Response Elements (HREs), it selectively modifies the gene expression of target tissues. This alters the synthesis rate of various proteins, enzymes, and structural components. This action influences the regulation of systems involved in anabolic processes across muscle, bone, and hematopoietic pathways.

Enzymatic Conversion and Metabolite Activity

The drug's overall biological activity is also shaped by its function as a prohormone. It is subject to conversion by the 5-alpha reductase enzyme into Dihydrotestosterone (DHT) and by the Aromatase enzyme into Estradiol (E2). These metabolites act on their own specific receptors, engaging in regulatory feedback loops and contributing to modulation of skeletal tissue and central signaling.

Dosage and Administration Information

How to Use Panteston (Testosterone Undecanoate)

Testosterone undecanoate is administered according to two distinct official usage patterns: a daily oral regimen or an intermittent intramuscular (IM) injection schedule, based on the specific dosage form. The medication is used as a long-term substitution therapy for conditions of male hypogonadism, with precise dosing and timing following established clinical protocols.


Administration Routes and Dosing Schedules

Administration Route Frequency and Dosing Contextual Requirements
Oral Capsules Typically started at 200 mg to 237 mg twice daily (morning and evening). Maintenance doses range up to 400 mg twice daily. Must be taken with food (a meal) to ensure proper absorption and systemic delivery.
Intramuscular Injection Initial doses of 750 mg or 1000 mg are given, followed by a second dose after a shortened interval (e.g., 4 to 6 weeks). Maintenance doses are then given every 10 to 14 weeks. Injection must be administered very slowly and deeply into the gluteal muscle.

Adjustment and Procedural Instructions

The dosage of the oral form is adjusted based on serum testosterone concentrations checked 7 days following treatment initiation or a dosage change. For the IM injection, the contents of the vial must be injected immediately after opening. Safety and efficacy are not established for use in males under 18 years old, and while limited data exist for older adults, no formal adjustment is specifically required. These instructions define the standardized, non-advisory protocol for the medicine's administration.

Recent Clinical Evidence

Research evidence / Overview of studies for Panteston (Testosterone)

Research on Restoring Testosterone Levels (Endocrine Evidence)

Studies used in research exploring how symptoms change over time have included short-term Randomized Controlled Trials (RCTs) and specialized pharmacokinetic (PK) studies. Researchers primarily examined achievement and sustained maintenance of total testosterone levels within the range considered normal for adult males. Research so far indicates that clinical trials reported measurements where total testosterone concentrations fell within the established normal range for the majority of observed patients shortly after treatment initiation. The follow-up durations were limited in the initial primary trials, and data particularly beyond one to two years are insufficient concerning the sustained stability of hormonal parameters.

Research on Functional and Symptom Management

Research examined outcomes related to physical discomfort and outcomes related to systemic or functional imbalance. This was primarily evaluated in RCTs using Patient-Reported Outcomes (PROs) applied in studies examining patient-reported experiences. Studies monitored changes in sexual function scores, objective metrics of Body Composition (lean mass and bone density), and subjective outcomes like mood and energy levels. Research highlights findings that describe patterns of increases in lean body mass and measurements related to scores on questionnaires assessing sexual desire. Findings indicate that results for subjective outcomes were often mixed and described as heterogeneous across different trials.

Research Gaps and Areas of Scientific Uncertainty

Evidence highlights what is known—and what is still uncertain. A key limitation is the absence of definitive, large-scale, long-term RCTs that are powered to primarily evaluate major health outcomes such as cardiovascular events or mortality. This kind of comparative evidence is lacking. The evidence quality varies across studies for functional outcomes. Additionally, follow-up durations were limited in the most controlled research, meaning that information regarding long-term outcomes on complex systems like bone and heart health is not fully established.

Frequently Asked Questions (FAQ)

Common questions about Panteston (Testosterone) (FAQ)


Q: How long does it typically take to notice the effects of Panteston?

Studies and official information indicate that the onset of effects can vary. Changes in mood may become detectable after approximately 3 to 6 weeks. Studies indicate that the full therapeutic effects may take longer to become apparent, sometimes requiring 18 to 30 weeks of ongoing treatment. Changes related to red blood cell count (erythropoiesis) may be evident after about three months.


Q: Is it normal to experience mood changes when starting Panteston?

Official information notes that individuals misusing high doses of testosterone have reported withdrawal symptoms including depressed mood and irritability upon stopping the drug. Separately, mood is listed as an outcome monitored in clinical studies, and effects on mood are debated in scientific literature. The official documentation does not define specific, common mood changes expected when starting the therapy at prescribed doses.


Q: Can Panteston affect fertility?

Yes, regulatory information indicates that testosterone products have the potential to damage fertility. In cases of misuse (using doses higher than prescribed), testosterone has been associated with lowered sperm count and male infertility. Information regarding fertility should be reviewed with a healthcare professional, particularly if planning a family.


Q: Do I need regular blood tests while using Panteston?

Regulatory requirements mandate periodic monitoring throughout treatment. This includes regular measurement of blood pressure, serum testosterone concentration, and hematocrit (to check red blood cell count). Additionally, monitoring of PSA (prostate-specific antigen) levels is necessary.


Q: Does Panteston cause weight gain or loss?

Official documents list weight increase as a common adverse reaction reported in clinical trials. Research evidence indicates that studies monitored changes in overall body composition, with findings describing increases in lean body mass.


Q: Does Panteston affect sleep or cause insomnia?

Official regulatory warnings note a risk for the worsening of sleep apnea, a condition where breathing stops and starts repeatedly during sleep. Furthermore, insomnia (difficulty sleeping) is one of the symptoms that has been reported as part of a withdrawal syndrome in cases where misuse of high doses is discontinued.


Q: Does Panteston affect hair growth or loss?

Officially documented side effects of testosterone products include androgenic effects. These effects may include increased hair growth (known as hirsutism) and, in some cases, the development of male-pattern baldness.


Q: What happens if I stop taking Panteston suddenly?

Regulatory documents describe withdrawal symptoms that have been reported by individuals who discontinue high doses of testosterone. These reported symptoms can include depressed mood, fatigue, irritability, and decreased libido. The decision to stop treatment is a medical matter and should be managed by a healthcare provider.


Q: Is Panteston used for bodybuilding or athletic performance?

The FDA label explicitly states that Panteston is not approved for use in men who are otherwise healthy or for enhancing athletic performance, strength, or physical appearance. Its official use is restricted to treating men who have a confirmed medical condition of hypogonadism (testosterone deficiency).


Q: Is Panteston a controlled substance?

Yes. Testosterone undecanoate is classified as a Schedule III controlled substance under the U.S. Controlled Substances Act. This classification is due to the drug's potential for abuse and dependence, necessitating strict dispensing and use regulations.


Q: Are there any specific dietary restrictions while taking Panteston?

Official documentation specifies that the oral capsule formulation needs to be taken with food (a meal) to ensure proper absorption and effectiveness. However, no specific restrictions on avoiding certain types of food or entire food groups are mandated in the labels.


Q: Is there a risk of developing dependence on Panteston?

The FDA requires a Warning section to alert prescribers to the potential for abuse and the risk of developing dependence associated with testosterone. The official warning is provided because of the potential for abuse and dependence, particularly when used in ways other than prescribed.


Q: What is the difference between Panteston and naturally produced testosterone?

Panteston is a synthetic derivative of testosterone and is technically an ester prodrug. This means it is a chemically modified version that includes an undecanoate side chain. This modification allows the medicine to be absorbed and released efficiently within the body, where it is then converted into the bio-identical, active testosterone molecule.


Q: Does Panteston require special handling or storage?

Yes, specific instructions are provided for its integrity and safety. It must be stored at a controlled room temperature and secured out of the sight and reach of children. The injectable solution requires protection from light and heat. Official labeling notes that a 30-minute observation period is mandated after administration of the injectable formulation due to the rare risk of a serious pulmonary reaction.


Q: Why is Panteston only available by prescription?

The prescription-only status is due to multiple factors. Panteston is classified as a Schedule III controlled substance and has the potential for dependence and abuse. Furthermore, it is only approved by regulatory agencies for men with a medically confirmed diagnosis of hypogonadism, which requires professional evaluation and ongoing monitoring for serious health risks.


Q: Can Panteston be taken with food?

Yes, for the oral capsule formulation, it is necessary to take the medication with food (a meal) to ensure the proper absorption required for the medicine to work effectively. However, taking food does not affect the administration of the intramuscular injection.


Q: What is the half-life or duration of effect for Panteston?

The duration of effect varies between the two formulations. For the injectable form, the half-life of the active ingredient has been reported as approximately 33.9 days, which allows for an extended dosing interval of about 10 to 14 weeks between maintenance doses. The half-life of the active testosterone released from the oral form is much shorter.


Q: How does Panteston differ from a general vitamin supplement?

Panteston is a prescription pharmaceutical classified as an androgen and a Schedule III controlled substance, used specifically for hormone replacement therapy in diagnosed deficiency. A vitamin or general supplement is an over-the-counter dietary adjunct intended to supplement nutrient intake and is not subject to the same strict regulatory controls or dispensing requirements.


Q: Is Panteston described as a cure for low testosterone?

No. Panteston is officially indicated by regulatory agencies for Testosterone Replacement Therapy (TRT) to address the symptoms and signs associated with a deficiency or absence of endogenous testosterone. Its purpose is to substitute the missing hormone, not to cure the underlying condition causing the deficiency.


Q: What are the regulatory approvals for Panteston outside of the US?

Regulatory documents confirm that testosterone undecanoate injection has been approved and marketed outside the U.S. since as early as November 2003. It is currently marketed under various brand names in numerous countries globally, subject to local regulatory requirements.


Q: Is it okay if I miss a dose of Panteston occasionally?

Official product instructions for the oral capsules specify that a missed dose should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is to be skipped. Instructions caution against taking two doses simultaneously to compensate for a single missed dose.


Q: What is the relationship between Panteston and prostate health?

The product information highlights a close relationship requiring monitoring. Panteston is contraindicated (should not be used) in men with known or suspected prostate cancer, as it can stimulate growth. It also requires the monitoring of PSA levels and may worsen pre-existing Benign Prostatic Hyperplasia (BPH), which is an enlargement of the prostate.


Q: Can Panteston affect mood disorders like anxiety or depression?

Regulatory information notes that when used inappropriately (abused), testosterone may be associated with psychiatric effects such as major depression and hostility. Additionally, withdrawal symptoms reported after discontinuation of high doses include depression and irritability.


Q: How do doctors decide who is eligible for Panteston treatment?

Official indications require a confirmed diagnosis of male hypogonadism. This diagnosis is established by the presence of associated clinical symptoms combined with consistently low serum testosterone concentrations, which must be confirmed by measurement on at least two separate mornings.


Q: Are there common user complaints about the experience of taking Panteston?

Official safety labels draw attention to the risks associated with the experience of the injectable form. These include the rare but serious risks of Pulmonary Oil Microembolism (POME) reactions and anaphylaxis, which is why a 30-minute observation period is mandated immediately following the injection.


Q: Does Panteston affect sexual function?

The medication is indicated to help address symptoms associated with testosterone deficiency, which include decreased libido (sexual desire) and erectile dysfunction. However, abuse of testosterone products has also been linked to decreased libido and male infertility.

How should Panteston (Testosterone) be stored and disposed of?

Storage and Disposal of Panteston (Testosterone)

As a Schedule III controlled substance, Panteston must be stored and disposed of according to strict regulatory guidelines to maintain product integrity and prevent misuse.


Storage Requirements

Item Official Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep in the original, tightly closed container; protect from light, moisture, and excessive heat.
Prohibited Do not refrigerate or freeze the injectable solution.
Child Safety Must be secured out of the sight and reach of children and pets.

Disposal Instructions

Unused or expired product should primarily be disposed of through an approved drug take-back program. If a take-back option is unavailable, the medicine must be mixed with an undesirable substance, placed into a sealed container, and then discarded in the household trash. Used needles and syringes must be handled as sharps waste and disposed of according to local regulations. The medicine must not be flushed down the drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Panteston (Testosterone) found in:

A-Z Index: